Rapidrugs
Reformulating hard-to-dissolve drugs into soluble, faster-acting forms
Rapidrugs
About
RapiDrugs reformulates active pharmaceutical ingredients that suffer from poor water solubility, removing excipients entirely and conjugating the API directly with a proprietary biocompatible Bio-organic Moiety to produce a soluble, liquid reformulation with 100 to 1,000-fold higher aqueous solubility, validated in vivo across NSAIDs and now extending to an anesthetic, an antibiotic and other therapeutic classes for licensing to pharma partners.
Startup Information
Company Name
RapiDrugs Private Limited
Location
Chennai
Incorporated Year
2024
Incubated With
IITM Incubation Cell
Sector
Healthcare & Biotech
Website
Focus Areas
Founder Details
Founder
Sanjib Senapati
Designation
Founder / Director
Bio
A professor whose lab research on molecular conjugation chemistry led to the Bio-organic Moiety platform RapiDrugs uses to reformulate poorly soluble drugs.
Founder
Shankha Banerjee
Designation
Co-founder / Director
Bio
Works alongside Sanjib Senapati taking RapiDrugs' reformulated APIs from lab validation toward licensed pharmaceutical products.